PNH
Clinical trials for PNH explained in plain language.
Never miss a new study
Get alerted when new PNH trials appear
Sign up with your email to follow new studies for PNH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood disease: drug trial shows promise in controlling PNH
Disease control CompletedThis study tested a drug called ravulizumab in 18 adults in China with a rare blood disease called PNH, which destroys red blood cells. The goal was to see if the drug could lower a key blood marker of cell damage and reduce the need for blood transfusions. Participants received …
Matched conditions: PNH
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 13, 2026 16:04 UTC
-
New PNH pill shows promise in Head-to-Head trial
Disease control CompletedThis study tested a new tablet called HSK39297 against the standard drug eculizumab in 73 adults with paroxysmal nocturnal hemoglobinuria (PNH) who had never taken complement inhibitors. The goal was to see if the new pill could raise hemoglobin levels and reduce the need for blo…
Matched conditions: PNH
Phase: PHASE3 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC